about
Insulin in central nervous system: more than just a peripheral hormoneGuidelines for the use and interpretation of assays for monitoring autophagyOxidative Stress Signaling in Alzheimers DiseaseThe impairment of insulin signaling in Alzheimer's diseaseTau phosphorylation in Alzheimer's disease: pathogen or protector?Physical exercise mitigates doxorubicin-induced brain cortex and cerebellum mitochondrial alterations and cellular quality control signalingCyanide preconditioning protects brain endothelial and NT2 neuron-like cells against glucotoxicity: role of mitochondrial reactive oxygen species and HIF-1αPhosphatase 2A Inhibition Affects Endoplasmic Reticulum and Mitochondria Homeostasis Via Cytoskeletal Alterations in Brain Endothelial CellsMetabolic fingerprints in testicular biopsies from type 1 diabetic patients.Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy?Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!Antioxidant therapy in Alzheimer's disease: theory and practice.Mitochondria: the missing link between preconditioning and neuroprotection.A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.Metformin in the diabetic brain: friend or foe?Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.Involvement of oxidative stress in Alzheimer disease.High-sugar diets, type 2 diabetes and Alzheimer's disease.SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilizationHydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities.Vascular oxidative stress in Alzheimer diseaseNeurofilament proteins in neurodegenerative diseases.Increased susceptibility to amyloid-β toxicity in rat brain microvascular endothelial cells under hyperglycemic conditions.Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?Therapeutic potential of oxidant mechanisms in Alzheimer's disease.Therapeutic opportunities in Alzheimer disease: one for all or all for one?Oxidative stress and neurodegeneration.Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.Neurodegenerative pathways in Parkinson's disease: therapeutic strategies.A second look into the oxidant mechanisms in Alzheimer's disease.Oxidative stress: the old enemy in Alzheimer's disease pathophysiology.The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease.Therapeutic options in Alzheimer's disease.Prevention and treatment of Alzheimer disease and aging: antioxidants.Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.Indices of metabolic dysfunction and oxidative stress.Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?Iron: the Redox-active center of oxidative stress in Alzheimer disease.
P50
Q21296648-C8FC3FEF-B0BB-4B7B-8D5C-DABE44153816Q21996341-A82ADED2-FF1C-41EE-88C7-5029142D45D8Q22241327-B9B4150C-1CD7-4A4E-A6B7-96D733F3FCECQ26863763-0787B606-C924-4F19-97EF-7BEC215EB7F0Q28244594-064C402F-A294-4510-BDDC-D33AB0472EDCQ28565360-B68E0F06-2D68-44FA-986F-0F97AD580946Q28575820-140363BE-02A6-4E06-9FA5-0F0D1CA6F2A1Q28771363-202B118D-7A6B-43B8-8749-29310E149D0BQ30375405-3E8375F0-E77D-4038-BFC4-430C9569C3F6Q33347411-5BAED244-30FF-4AC4-A712-147B82FFC397Q33364882-A98EFC39-0EDC-46B2-944C-C211E1D92604Q34066474-CD1B45B1-E862-4B32-B185-AF903835017DQ34073859-0A41BA5E-C4E5-459D-9E71-9DBE4C17C540Q34073879-DB3AED4F-4A07-4662-A484-C634ADB71DA9Q34298773-5900CFC5-F1DD-41CB-8B08-02D16F4ECAF3Q34357977-8197AC5A-DE8D-40A4-B5BD-A92030336E2AQ34402849-E166240C-5093-414F-9698-6B1731523785Q34545547-3A02506F-8681-42B7-9854-E3094C4EEDDDQ34651637-BC08D229-7FB1-4D4C-B462-2D308BF0FDACQ34729713-890BD876-E41D-45D5-8E42-A09B4EDAAF15Q35711947-30FA9A5F-84CF-4BA2-85AC-AF9143C4D9E2Q35902875-682E043F-784C-4BB6-A569-466A1D9D3637Q35951646-8F6EBAC0-2893-43CA-B08C-46BF234A175FQ35975762-7B0FE75D-C933-440B-9BD3-C1079325C9A2Q36061470-E695CDB9-F927-42BE-84D3-C19DD8EEC93FQ36063447-AC7F0630-3DB2-4A5A-A9E9-AB705E643495Q36106911-73957EBE-ADA4-433B-994B-DEAE59137387Q36126607-A2DE138A-B205-433F-9943-E2B052ED511DQ36203957-D9916E3D-A821-43B0-B901-8768FA67C89EQ36230545-8AF55950-C1D1-4FFC-8921-6D9D52364A5CQ36230549-6B72D60D-45C3-4BB6-876F-75597584C30EQ36266217-759ACF9A-41BB-46A5-8460-4AC8B20FD278Q36296822-65C36DE2-5AFC-4831-8F2D-BC9E2D481B98Q36413791-46D3CBA9-AB24-4049-96A1-0726189A98C0Q36511328-5F97147F-48DA-4D0E-9949-664B52F1F6AAQ36738037-AC78E86A-D049-4932-9164-546B9EB5E180Q36742834-66F2BB33-8A6F-4192-B0FC-AF0C6A2E804AQ36753383-03D4CBD0-B4F2-4F15-BE8F-CA2497B64CDFQ36817040-4EDDEA0F-0934-4121-ADE1-2B153E9D39ACQ36824768-035B3C4F-9DEE-4927-954D-9EB8AFFD4ED2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Paula I. Moreira
@ast
Paula I. Moreira
@en
Paula I. Moreira
@es
Paula I. Moreira
@sl
type
label
Paula I. Moreira
@ast
Paula I. Moreira
@en
Paula I. Moreira
@es
Paula I. Moreira
@sl
altLabel
Moreira PI
@en
Paula I Moreira
@en
Paula I. Moreira
@en
Paula Moreira
@en
prefLabel
Paula I. Moreira
@ast
Paula I. Moreira
@en
Paula I. Moreira
@es
Paula I. Moreira
@sl
P1053
B-3608-2009
P106
P1153
56038291200
56984089100
P2038
Paula_Moreira3
P21
P214
3992154387143830970001
P31
P3829
P4012
P496
0000-0001-5177-6747